Advances in the mass-spectrometry-based characterization of tau PTMs have indicated that, like the stereotypical progression of tau pathology through brain regions, PTMs also probabilistically accumulate in a specific order as AD progresses [24]. The gene discussed is MAPT; the disease is Alzheimer disease.